Rani Therapeutics Inc.

NASDAQ: RANI · Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM
0.55
0.00%
After-hours: Aug 15, 2025, 07:04 PM EDT

Rani Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.76M 5.86M 27.01M 117.45M
Short-Term Investments
23.88M 42.67M 71.47M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
246K 246K n/a n/a
Receivables
428K 200K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.68M 800K 500K n/a
Total Current Assets
29.74M 50.85M 100.92M 119.59M
Property-Plant & Equipment
6.64M 6.82M 7.1M 4.61M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
6.89M 7.07M 7.1M 4.61M
Total Assets
36.63M 57.92M 108.03M 124.21M
Account Payables
1.36M 648K 1.46M 1.08M
Deferred Revenue
n/a 1.21M n/a n/a
Short-Term Debt
15M 4.9M 1.01M n/a
Other Current Liabilities
283K 202K -415K 126K
Total Current Liabilities
19.89M 7.99M 4.82M 2.64M
Long-Term Debt
9.61M 24.48M 29.15M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
13.25M 24.48M 29.21M n/a
Total Liabilities
33.14M 32.47M 34.02M 2.64M
Total Debt
29.71M 30.1M 30.21M n/a
Common Stock
5K 5K 5K 5K
Retained Earnings
-102.91M -72.89M -38.92M -8.33M
Comprehensive Income
5K -12K -73K n/a
Shareholders Equity
1.99M 12.87M 36.85M 47.41M
Total Investments
23.88M 42.67M 71.47M n/a